Overview: Scrub Typhus IgM Rapid TestIntroduction: The Scrub Typhus IgM Rapid Test screens scrub typhus IgM to diagnose recent exposure, causing headache or rash. Aligned with 2023 IDSA guidelines, it uses rapid immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected acute scrub typhus.
Other Names: Scrub Typhus IgM Rapid Assay, Orientia IgM Rapid Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Scrub typhus rapid testing began in the 1990s with point-of-care diagnostics. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Screens scrub typhus IgM to diagnose recent exposure, guides treatment, and evaluates patients with headache or rash.
Test Parameters: 1. Scrub Typhus IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of headache, rash, or scrub typhus exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document headache, rash, or history of scrub typhus exposure. Include current medications, especially doxycycline.
Consent: Written consent required, detailing the tests purpose, scrub typhus implications, and risks of sample collection.
Procedural Considerations: Uses rapid immunochromatographic assay to screen scrub typhus IgM. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories or point-of-care settings.
Factors Affecting Result Accuracy: Sample hemolysis or early testing can affect results. Cross-reactivity with rickettsial infections may reduce specificity.
Clinical Significance: Positive IgM confirms recent scrub typhus exposure, guiding doxycycline therapy. Negative results may require confirmatory EIA or PCR.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Scrub typhus IgG, EIA, or PCR to confirm recent exposure.
Test Limitations: Non-specific for certain rickettsial infections; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Scrub Typhus Guidelines, 2023; Clinical Infectious Diseases, Varghese GM, 2022.
